Skip to main content
. 2023 Nov 2;30(11):9676–9688. doi: 10.3390/curroncol30110702

Figure 4.

Figure 4

Frequency and distribution of DNA alterations in genes of interest in TCGA GBM set that putatively determine differential sensitivity to proteasome inhibition. The oncoplot shows the mutual exclusivity or co-occurrence of mutations in genes shown to affect the response to proteasome inhibitors, as demonstrated in in vitro and in vivo studies.